Table 1.
Analysis | Patients | Controls | ||
---|---|---|---|---|
n (M/F) | Age median (range) | n (M/F) | Age median (range) | |
S-NFL S-GFAP |
49 (20/29) | 65 (39–86) | 45 (17/28) | 64 (40–86) |
S-FGF-21 S-GDF-15 |
49 (20/29) | 65 (39–86) | 24 (10/14) | 63 (47–85) |
P-Metabolite profiling | 43 (19/24) | 65 (39–86) | 48 (18/30) | 65 (34–86) |
S-CK S-Creatinine |
49 (20/29) | 65 (39–86) | - (reference values) | - (reference values) |
Symptom score | 43 (16/27) | 65 (39–85) | - | - |